ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Michael West Ph.D., President and Chief Scientific Officer highlighted the Company’s ACTCellerate Platform, yesterday, at the 2nd Annual Stem Cell Summit, in San Diego. While the Company’s core focus is advancing its therapies related to the eye, vascular system, and skin, the Company believes this platform could augment the potential product applications from what many believe to be the most powerful cell, the human embryonic stem cell.
